As in adults, more aggressive cancer behavior is expected in cases harboring p.V600E or other BRAF point mutations or BRAF-like fusions (e.g., RET/PTC1, NTRK3/ETV6, ALK rearrangements), although these correlations remain unconfirmed in children [46]. This evidence concerns the gene BRAF and cancer.